PURPOSE: To determine the role of DNA repair in hypoxic radioresistance. METHODS AND MATERIALS: Chinese hamster cell lines with mutations in homologous recombination (XRCC2, XRCC3, BRAC2, RAD51C) or nonhomologous end-joining (DNA-PKcs) genes were irradiated under normoxic (20% oxygen) and hypoxic (<0.1% oxygen) conditions, and the oxygen enhancement ratio (OER) was calculated. In addition, Fanconi anemia fibroblasts (complementation groups C and G) were compared with fibroblasts from nonsyndrome patients. RAD51 foci were studied using immunofluorescence. RESULTS: All hamster cell lines deficient in homologous recombination showed a decrease in OER (1.5-2.0 vs. 2.6-3.0 for wild-types). In contrast, the OER for the DNA-PKcs-deficient line was comparable to wild-type controls. The two Fanconi anemia cell strains also showed a significant reduction in OER. The OER for RAD51 foci formation at late times after irradiation was considerably lower than that for survival in wild-type cells. CONCLUSION: Homologous recombination plays an important role in determining hypoxic cell radiosensitivity. Lower OERs have also been reported in cells deficient in XPF and ERCC1, which, similar to homologous recombination genes, are known to play a role in cross-link repair. Because Fanconi anemia cells are also sensitive to cross-linking agents, this strengthens the notion that the capacity to repair cross-links determines hypoxic radiosensitivity.
PURPOSE: To determine the role of DNA repair in hypoxic radioresistance. METHODS AND MATERIALS: Chinese hamster cell lines with mutations in homologous recombination (XRCC2, XRCC3, BRAC2, RAD51C) or nonhomologous end-joining (DNA-PKcs) genes were irradiated under normoxic (20% oxygen) and hypoxic (<0.1% oxygen) conditions, and the oxygen enhancement ratio (OER) was calculated. In addition, Fanconi anemia fibroblasts (complementation groups C and G) were compared with fibroblasts from nonsyndrome patients. RAD51 foci were studied using immunofluorescence. RESULTS: All hamster cell lines deficient in homologous recombination showed a decrease in OER (1.5-2.0 vs. 2.6-3.0 for wild-types). In contrast, the OER for the DNA-PKcs-deficient line was comparable to wild-type controls. The two Fanconi anemia cell strains also showed a significant reduction in OER. The OER for RAD51 foci formation at late times after irradiation was considerably lower than that for survival in wild-type cells. CONCLUSION: Homologous recombination plays an important role in determining hypoxic cell radiosensitivity. Lower OERs have also been reported in cells deficient in XPF and ERCC1, which, similar to homologous recombination genes, are known to play a role in cross-link repair. Because Fanconi anemia cells are also sensitive to cross-linking agents, this strengthens the notion that the capacity to repair cross-links determines hypoxic radiosensitivity.
Authors: S Masunaga; Y Matsumoto; G Kashino; R Hirayama; Y Liu; H Tanaka; Y Sakurai; M Suzuki; Y Kinashi; A Maruhashi; K Ono Journal: Br J Radiol Date: 2010-09 Impact factor: 3.039
Authors: Mohammad Saki; Haruhiko Makino; Prashanthi Javvadi; Nozomi Tomimatsu; Liang-Hao Ding; Jennifer E Clark; Elaine Gavin; Kenichi Takeda; Joel Andrews; Debabrata Saha; Michael D Story; Sandeep Burma; Chaitanya S Nirodi Journal: Mol Cancer Res Date: 2017-08-11 Impact factor: 5.852
Authors: Verena M Kuhnert; Lisa A Kachnic; Li Li; Martin Purschke; Liliana Gheorghiu; Richard Lee; Kathryn D Held; Henning Willers Journal: Int J Radiat Biol Date: 2009-06 Impact factor: 2.694
Authors: Wei-Yu Lin; Nicola J Camp; Lisa A Cannon-Albright; Kristina Allen-Brady; Sabapathy Balasubramanian; Malcolm W R Reed; John L Hopper; Carmel Apicella; Graham G Giles; Melissa C Southey; Roger L Milne; Jose I Arias-Pérez; Primitiva Menéndez-Rodríguez; Javier Benítez; Magdalena Grundmann; Natalia Dubrowinskaja; Tjoung-Won Park-Simon; Thilo Dörk; Montserrat Garcia-Closas; Jonine Figueroa; Mark Sherman; Jolanta Lissowska; Douglas F Easton; Alison M Dunning; Preetha Rajaraman; Alice J Sigurdson; Michele M Doody; Martha S Linet; Paul D Pharoah; Marjanka K Schmidt; Angela Cox Journal: J Med Genet Date: 2011-05-31 Impact factor: 6.318